Bamboo Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $645M
Latest Deal Amount

Bamboo Therapeutics General Information

Description

Developer of gene therapies for the treatment of monogenic disorders. The company specializes in developing therapeutic reagents to diagnose diseases related to central nervous system and neuromuscular conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Parent Company
Primary Office
  • 870 Martin Luther King Jr Boulevard
  • Chapel Hill, NC 27514
  • United States
+1 (919) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bamboo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Aug-2016 $645M 000.00 00000 Completed Startup
1. Early Stage VC 11-Feb-2016 000.00 000.00 Completed Startup
To view Bamboo Therapeutics’s complete valuation and funding history, request access »

Bamboo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of gene therapies for the treatment of monogenic disorders. The company specializes in developing therapeutic
Biotechnology
Chapel Hill, NC
000.00
0000 0000-00-00
000000&0 000.00

00000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000000000000
Rockville, MD
000 As of 0000
00000
00000000000 00000

0000000

lit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sun
0000000000000
Bainbridge Island, WA
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bamboo Therapeutics Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD 000 00000 00000000000 00000
0000000 000 Angel-Backed Bainbridge Island, WA 00000 0000000000 00000
00000000 000000000 Private Equity-Backed San Francisco, CA 000 00000 000000&0 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
You’re viewing 5 of 24 competitors. Get the full list »

Bamboo Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Richard Samulski Ph.D Co-Founder, Chief Scientific Officer & Executive Chairman
Sharon hesterlee Ph.D Executive Vice President, Patient Advocacy and Public Affairs
Richard Smith Ph.D Senior Vice President of Corporate Communications and External Affairs
Cynthia Rask Chief Medical Officer
Sheila Mikhail JD Co-Founder, Chief Executive Officer & Board Member
You’re viewing 5 of 10 executive team members. Get the full list »

Bamboo Therapeutics Board Members (3)

Name Representing Role Since
Richard Samulski Ph.D Bamboo Therapeutics Co-Founder, Chief Scientific Officer & Executive Chairman 000 0000
Sheila Mikhail JD Self Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Bamboo Therapeutics’s complete board members history, request access »

Bamboo Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Bamboo Therapeutics’s complete investors history, request access »

Bamboo Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 0000 08-Jan-2016 000000000 00000 00 Buildings and Property 0. 0000 00000000 00.0
To view Bamboo Therapeutics’s complete investments history, request access »